SIR,
Fitchett and Seabright1 have shown that deletion of the Xq distal segment occurs in a number of cells from patients with fra(Xq). To explain this finding we put forward the hypothesis that the fragile site is manifested in vitro only in the first cell division, whereas deletions may occur during the second and third divisions, thus masking the expression of the fragility.
To test this possibility we studied the patterns of SCE using a low concentration of BrdU (2 ,ug/ml instead of the standard 10 ,ug/ml, which inhibits the expression of the fragile site). Our hypothesis was not confirmed, however, because the fra(X) was manifested in the first, second, and third cell divisions (figure). 
